カテゴリ： GlobalData, アメリカ, 企業調査

Foundation Medicine Inc (FMI)-医療機器分野：企業M&A・提携分析

◆英語タイトル：Foundation Medicine Inc (FMI) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA8011701
◆発行会社（調査会社）：GlobalData
◆発行日：2017年12月13日
◆ページ数：69
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd is a healthcare products provider that offers cancer care solutions. The company offers molecular information and cancer research programs. It offers clinical products which include FoundationOne for solid tumors and FoundationOne Heme for hematologic malignancies and sarcomas and others. It also offers additional materials, services, and real-time data through its technology products. The company partners with biotech and pharmaceutical companies to develop targeted cancer therapies and active clinical trials. Foundation Medicine is headquartered in Cambridge, Massachusetts, the US.

Foundation Medicine Inc (FMI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Foundation Medicine Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Foundation Medicine Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Foundation Medicine Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Foundation Medicine Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Foundation Medicine Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Foundation Medicine Inc, Medical Equipment, Deal Details 12
Venture Financing 12
Cota Raises Funds through Venture Financing 12
Foundation Medicine Raises US$56 Million In Series B Financing 13
Foundation Medicine Secures Additional US$8.5 Million In Series A Venture Financing 15
Foundation Medicine Raises US$10 Million In Venture Financing 17
Partnerships 18
Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech 18
Foundation Medicine Enters into Agreement with AstraZeneca 19
Foundation Medicine Enters into Agreement with Mirati Therapeutics 20
IMS Health Enters into Agreement with Foundation Medicine 21
Foundation Medicine Enters into Co-Development Agreement with Flatiron Health 22
Foundation Medicine Extends Co-Development Agreement With Clovis Oncology 23
Foundation Medicine Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center 24
Foundation Medicine Enters Into Agreement With Agios Pharma To Develop Cancer Diagnostics 25
Foundation Medicine Enters Into Agreement With Eisai For Genomic Profiling And Diagnostic Discovery 26
Foundation Medicine Enters Into Co-Development Agreement With Clovis Oncology 27
Foundation Medicine Extends Co-Development Agreement With Novartis 28
Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics 29
Foundation Medicine Enters Into An Agreement With Novartis 30
Foundation Medicine Expands Co-Development Agreement With Novartis 31
Equity Offering 32
Foundation Medicine Raises USD250 Million in Private Placement of Shares 32
Foundation Medicine Withdraws Public Offering Of Shares For Up To US$150 Million 33
Foundation Medicine Completes IPO Of Shares For US$122 Million 34
Foundation Medicine Inc – Key Competitors 35
Foundation Medicine Inc – Key Employees 36
Foundation Medicine Inc – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 38
Strategy And Business Planning 38
Jun 08, 2017: ASCO and Foundation Medicine Announce Collaboration to Help Research Sites Identify Potential Participants for the Targeted Agent and Profiling Utilization Study 38
Financial Announcements 39
Nov 01, 2017: Foundation Medicine Announces 2017 Third Quarter Results and Recent Highlights 39
Aug 01, 2017: Foundation Medicine Announces 2017 Second Quarter Results and Recent Highlights 40
May 09, 2017: Foundation Medicine Announces 2017 First Quarter Results and Recent Highlights 42
Feb 22, 2017: Foundation Medicine Announces 2016 Fourth Quarter and Year-End Results, Recent Highlights and 2017 Outlook 44
Jan 09, 2017: Foundation Medicine Reports Preliminary 2016 Results 45
Nov 02, 2016: Foundation Medicine Announces 2016 Third Quarter Results and Recent Highlights 47
Aug 02, 2016: Foundation Medicine Announces 2016 Second Quarter Results and Recent Highlights 49
May 03, 2016: Foundation Medicine Announces 2016 First Quarter Results and Recent Highlights 51
Feb 23, 2016: Foundation Medicine Announces 2015 Fourth Quarter and Year-End Results, Recent Highlights and 2016 Outlook 52
Corporate Communications 53
Oct 10, 2017: Foundation Medicine Appoints Tom Civik as Chief Commercial Officer 53
Jan 06, 2017: Foundation Medicine Announces Executive Leadership Transition 54
Oct 27, 2016: Foundation Medicine Adds Life Sciences Leader Michael R. Dougherty to its Board of Directors 55
Legal and Regulatory 56
Nov 07, 2017: Caris Life Sciences Files Patent Infringement Suit against Foundation Medicine 56
Government and Public Interest 57
Aug 15, 2017: Cancer Treatment Centers Of America And Foundation Medicine Join Forces to Advance Precision Cancer Treatment 57
Product News 58
May 18, 2017: Foundation Medicine and Its Collaborators to Present New Data at ASCO 2017 Supporting the Integration of Comprehensive Genomic Profiling in Personalized Clinical Care in Oncology 58
Aug 22, 2016: Foundation Medicine Adds New Immunotherapy Features to Its Market-Leading Products 60
May 17, 2016: Foundation Medicine Receives Patent Covering Fundamental Methods in Comprehensive Genomic Analysis in Cancer 61
03/23/2016: Foundation Medicine and Memorial Sloan Kettering Publish Validation Data for FoundationOne Heme in the Journal Blood 62
03/17/2016: Foundation Medicine Announces Presentations at the AACR Annual Meeting 2016 64
03/16/2016: Foundation Medicine Presents New Data at the 2016 USCAP Annual Meeting Underscoring Importance of Comprehensive Genomic Profiling in Cancer Care 66
Other Significant Developments 68
Feb 25, 2016: Foundation Medicine Announces First-Ever Public Release of Broad Pediatric Data From FoundationCORE to Accelerate the Development of Precision Medicine Strategies for Pediatric Cancers 68
Appendix 69
Methodology 69
About GlobalData 69
Contact Us 69
Disclaimer 69

List of Tables
Foundation Medicine Inc, Medical Equipment, Key Facts, 2016 2
Foundation Medicine Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Foundation Medicine Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Foundation Medicine Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Foundation Medicine Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Foundation Medicine Inc, Deals By Market, 2011 to YTD 2017 9
Foundation Medicine Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Cota Raises Funds through Venture Financing 12
Foundation Medicine Raises US$56 Million In Series B Financing 13
Foundation Medicine Secures Additional US$8.5 Million In Series A Venture Financing 15
Foundation Medicine Raises US$10 Million In Venture Financing 17
Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech 18
Foundation Medicine Enters into Agreement with AstraZeneca 19
Foundation Medicine Enters into Agreement with Mirati Therapeutics 20
IMS Health Enters into Agreement with Foundation Medicine 21
Foundation Medicine Enters into Co-Development Agreement with Flatiron Health 22
Foundation Medicine Extends Co-Development Agreement With Clovis Oncology 23
Foundation Medicine Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center 24
Foundation Medicine Enters Into Agreement With Agios Pharma To Develop Cancer Diagnostics 25
Foundation Medicine Enters Into Agreement With Eisai For Genomic Profiling And Diagnostic Discovery 26
Foundation Medicine Enters Into Co-Development Agreement With Clovis Oncology 27
Foundation Medicine Extends Co-Development Agreement With Novartis 28
Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics 29
Foundation Medicine Enters Into An Agreement With Novartis 30
Foundation Medicine Expands Co-Development Agreement With Novartis 31
Foundation Medicine Raises USD250 Million in Private Placement of Shares 32
Foundation Medicine Withdraws Public Offering Of Shares For Up To US$150 Million 33
Foundation Medicine Completes IPO Of Shares For US$122 Million 34
Foundation Medicine Inc, Key Competitors 35
Foundation Medicine Inc, Key Employees 36
Foundation Medicine Inc, Other Locations 37

★海外企業調査レポート[Foundation Medicine Inc (FMI)-医療機器分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Rose Petroleum plc (ROSE)：石油・ガス：M&Aディール及び事業提携情報
    Summary Rose Petroleum plc (Rose Petroleum), formerly Vane Minerals plc is an oil and gas company. The company explores and produce oil and gas, silver, gold, copper, and uranium deposits across the US and Mexico. Its oil and gas project is located in Paradox Basin in Utah, the US, which covers over …
  • Veristat LLC-製薬・医療分野：企業M&A・提携分析
    Summary Veristat LLC (Veristat), a subsidiary of Veristat Holding Inc is a clinical research organization that conducts clinical trials. The organization offers clinical monitoring, clinical project management, data management, CDISC implementation, biostatistics, medical writing, project management …
  • Boston Pharmaceuticals Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Boston Pharmaceuticals Inc (Boston Pharma) is a drug development company that develops new drugs for unmet needs. The company acquires and advances various drug candidates from investigational new drug application (IND) through Phase 2 including BOS161721, BOS172767, BOS173717, BOS172722, BO …
  • TriGranit Corporation：企業の戦略・SWOT・財務情報
    TriGranit Corporation - Strategy, SWOT and Corporate Finance Report Summary TriGranit Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • James Halstead PLC (JHD)：企業の財務・戦略的SWOT分析
    Summary James Halstead PLC (James Halstead) is a manufacturer and distributor of flooring products that provides commercial building equipment and flooring products. The company provides manufacturing of commercial, contract and consumer floorings. It also offers dyeing, finishing and later waterpro …
  • INTL FCStone Inc：企業の戦略・SWOT・財務情報
    INTL FCStone Inc - Strategy, SWOT and Corporate Finance Report Summary INTL FCStone Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • International Games System Co Ltd：企業の戦略・SWOT・財務分析
    International Games System Co Ltd - Strategy, SWOT and Corporate Finance Report Summary International Games System Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • IMI plc：企業の戦略・SWOT・財務分析
    IMI plc - Strategy, SWOT and Corporate Finance Report Summary IMI plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Dassault Systemes SA (DSY)：医療機器：M&Aディール及び事業提携情報
    Summary Dassault Systemes SA (Dassault) is a 3D experience company that offers software applications and services. Dassault offers consulting services in the areas of design, deployment, support, training, and engineering services. The company serves various industries including aerospace and defens …
  • Brazil Fast Food Corp.：企業の戦略・SWOT・財務情報
    Brazil Fast Food Corp. - Strategy, SWOT and Corporate Finance Report Summary Brazil Fast Food Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Austin Industries Inc：企業の戦略・SWOT・財務分析
    Austin Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Austin Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Cenovus Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Cenovus Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Cenovus Energy Inc (Cenovus Energy) is an integrated energy company, which explores, develops, produces and markets crude oil, natural gas liquids (NGLs) and natural gas. Cenovus Energy produces n …
  • Efore Oyj (EFO1V)：企業の財務・戦略的SWOT分析
    Efore Oyj (EFO1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sheetz, Inc.：企業の戦略・SWOT・財務分析
    Sheetz, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sheetz, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Abbott Laboratories (ABT)：企業の財務・戦略的SWOT分析
    Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Nigerian Breweries Plc：企業の戦略・SWOT・財務情報
    Nigerian Breweries Plc - Strategy, SWOT and Corporate Finance Report Summary Nigerian Breweries Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Sunwin Stevia International Inc (SUWN)：企業の財務・戦略的SWOT分析
    Sunwin Stevia International Inc (SUWN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Weifa ASA (WEIFA)-製薬・医療分野：企業M&A・提携分析
    Summary Weifa ASA (Weifa), formerly Aqualis ASA, is a pharmaceutical company that conducts the research and development, manufacture, distribution and sales of pharmaceutical products, lifestyle products and solutions. The company has over the counter (OTC) pharmaceutical market in Norway offering p …
  • Onex Corporation (ONEX)：企業の財務・戦略的SWOT分析
    Onex Corporation (ONEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Paratek Pharmaceuticals Inc (PRTK)：製薬・医療：M&Aディール及び事業提携情報
    Summary Paratek Pharmaceuticals Inc (Paratek) is a biopharmaceutical company that develops and commercializes therapies based on tetracycline chemistry. Omadacycline (antibiotic), the company’s lead product candidate is an aminomethylcycline which acts against gram-negative, gram-positive, and atypi …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆